Allecra Therapeutics
Latest round
- Series B
Last raised
- Jun 2016
Total raised
- $44M
Investors
- 5
About Allecra Therapeutics
Founded in 2013 in France, Allecra Therapeutics specializes in the development of therapies addressing antibiotic resistance. The founder, Nicholas Benedict, has a history in the life sciences sector, although specific previous ventures are not detailed.Allecra Therapeutics specializes in developing innovative therapies targeting antibiotic resistance, particularly with its lead product candidate, cefepime/enmetazobactam. This antibiotic provides a critical treatment option for complicated urinary tract infections (cUTIs) caused by Extended-Spectrum ß-lactamase (ESBL)-producing pathogens. Clinical trials indicate it outperforms standard treatments, aiming to meet the urgent healthcare challenge of antibiotic resistance.90.Allecra Therapeutics plans to expand its product portfolio with new antibiotic therapies while targeting key markets in Europe and North America by 2025. The company aims to broaden its market access through strategic partnerships and licensing agreements, enhancing distribution channels across healthcare providers and hospitals.
Who invested in Allecra Therapeutics
5 investors across 2 rounds
See all investors in Allecra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allecra Therapeutics
Who invested in Allecra Therapeutics?
Allecra Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allecra Therapeutics raised?
Allecra Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Allecra Therapeutics last raise money?
Allecra Therapeutics's most recent round on record is a Series B, in Jun 2016.
What does Allecra Therapeutics do?
Founded in 2013 in France, Allecra Therapeutics specializes in the development of therapies addressing antibiotic resistance.
Where is Allecra Therapeutics headquartered?
Allecra Therapeutics is headquartered in France.
Which VCs invest in companies like Allecra Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Allecra Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Allecra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.